DNA Methylation and GSTP1 Gene Regulation in Gliomas
胶质瘤中的 DNA 甲基化和 GSTP1 基因调控
基本信息
- 批准号:6647736
- 负责人:
- 金额:$ 34.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-08-30 至 2008-08-31
- 项目状态:已结题
- 来源:
- 关键词:DNA methylationacetylationallelesathymic mousecell linechromatinclinical researchdrug resistancegene expressiongenetic promoter elementgenetic regulationgenetic transcriptiongliomaglutathione transferasehistoneshuman tissuemolecular oncologyneoplasm /cancer geneticsprotein bindingtranscription factor
项目摘要
DESCRIPTION (provided by applicant): Human malignant gliomas are among the most
intractable of human tumors to therapy. There is, therefore, a continued urgent
need for a better understanding of the molecular mechanisms underlying the
malignant growth, progression and therapeutic failure in these tumors. Among
the most common molecular alteration in brain and other human tumors is the
over-expression of the glutathione S-transferase P1 (GSTP1) gene. This
application is based on several important findings on the GSTP1 gene in human
gliomas that have been made in our laboratory. These include the discovery of
allelopolymorphism of the GSTP1 gene locus and the demonstration that GSTP1
gene expression in gliomas is highly heterogeneous and is a strong prognostic
indicator of patient survival and response to therapy. Our goal in this
application is to better understand the molecular mechanisms that regulate
differential GST-pi expression among malignant gliomas. We will test the
hypothesis that the heterogeneity in GSTP1 expression among gliomas results
from differential transcriptional activity of the GSTP1 gene and that
differences in methylation of CpGs in the 5'-region of the GSTP1 gene results
in altered chromatin structure and altered transcription factor binding to the
GSTP1 promoter, which ultimately accounts for the differences in GSTP1
expression between gliomas. Using both primary specimens and cell lines of
human malignant gliomas, we will a) Determine be extent to which differential
GSTP1 expression among malignant gliomas is regulated at the transcriptional
level; b) Determine the relationship between methylation status of CpGs in the
5?-region of the GSTP1 gene and the transcriptional activity and expression of
the GSTP1 gene in gliomas, and examine whether different GSTP1 alleles are
differentially methylated and expressed, and whether GSTP1 gene methylation
status is associated with drug resistance in gliomas; c) Investigate the
effects of the methylation of CpGs in the GSTP1 5'-region on transcription
factor binding to the GSTP1 promoter region and on GSTP1 promoter function; d)
Examine whether methylation of the GSTP1 gene is associated with altered
histone acetylation/deacetylation and chromatin structure at the GSTP1 gene
locus, and whether these together determine GSTP1 expression in gliomas. The
proposed studies represent a well-focused innovative research effort. The
results should yield important new information on DNA methylation-related
mechanisms involved in the over-expression of the GSTP1 gene in human gliomas
and will contribute to efforts in the rational development of more effective
agents and treatment strategies for these tumors. The results should also lead
to a better understanding of the malignant process, not only in gliomas, but
also in many other human cancer characterized be GSTP1 over-expression.
描述(申请人提供):人类恶性胶质瘤是最常见的
难以治愈的人类肿瘤。因此,有一个持续的紧急情况
需要更好地了解潜在的分子机制
这些肿瘤的恶性生长、进展和治疗失败。其中
大脑和其他人类肿瘤中最常见的分子变化是
谷胱甘肽S转移酶P1基因的过表达。这
应用是基于对人类GSTP1基因的几个重要发现
我们实验室制造的神经胶质瘤。其中包括发现了
GSTP1基因座的等位基因多态性及GSTP1的研究
胶质瘤的基因表达具有高度的异质性,是一个很强的预后指标。
患者生存和对治疗反应的指标。我们在这方面的目标
应用是为了更好地理解调控的分子机制
GST-pi在恶性胶质瘤中的表达差异。我们将测试
假设GSTP1在胶质瘤中表达的异质性导致
由于GSTP1基因转录活性的差异
GSTP1基因5‘端CpGS甲基化结果差异
在改变染色质结构和改变转录因子结合到
GSTP1启动子,这最终解释了GSTP1的差异
胶质瘤之间的表达。利用原代标本和细胞系
人类恶性胶质瘤,我们将a)确定分化程度
GSTP1在恶性胶质瘤中的表达在转录水平上的调节
水平;b)确定CPGS的甲基化状态与
GSTP1基因5?区及其转录活性和表达
GSTP1基因,并检测不同的GSTP1等位基因是否
差异甲基化和表达以及GSTP1基因甲基化是否
状态与胶质瘤的耐药性有关;c)调查
GSTP15‘-区CPGS甲基化对转录的影响
与GSTP1启动子区域结合的因子和GSTP1启动子功能;d)
检查GSTP1基因甲基化是否与改变有关
GSTP1基因的组蛋白乙酰化/去乙酰化与染色质结构
以及这些因素是否共同决定了GSTP1在胶质瘤中的表达。这个
拟议的研究代表了一项重点明确的创新研究工作。这个
结果应该会产生与DNA甲基化相关的重要新信息
GSTP1基因在人脑胶质瘤中过度表达的机制
并将为努力在合理发展中更加有效作出贡献
这些肿瘤的药物和治疗策略。结果也应该领先于
为了更好地了解恶性过程,不仅是在胶质瘤中,而且
在许多其他人类癌症中也以GSTP1过度表达为特征。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FRANCIS ALI-OSMAN其他文献
FRANCIS ALI-OSMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FRANCIS ALI-OSMAN', 18)}}的其他基金
Project 3 Supplement - A Novel Cellular Tumor Vaccine Strategy for Mutant IDH1 glioma
项目 3 补充 - 针对突变 IDH1 神经胶质瘤的新型细胞肿瘤疫苗策略
- 批准号:
10184915 - 财政年份:2014
- 资助金额:
$ 34.03万 - 项目类别:
P53-dependent GSTP1 Gene Regulation and Glioma Drug Resistance
P53 依赖性 GSTP1 基因调控和神经胶质瘤耐药性
- 批准号:
8101949 - 财政年份:2010
- 资助金额:
$ 34.03万 - 项目类别:
P53-dependent GSTP1 Gene Regulation and Glioma Drug Resistance
P53 依赖性 GSTP1 基因调控和神经胶质瘤耐药性
- 批准号:
8462458 - 财政年份:2010
- 资助金额:
$ 34.03万 - 项目类别:
P53-dependent GSTP1 Gene Regulation and Glioma Drug Resistance
P53 依赖性 GSTP1 基因调控和神经胶质瘤耐药性
- 批准号:
8245147 - 财政年份:2010
- 资助金额:
$ 34.03万 - 项目类别:
相似国自然基金
海马神经元胆固醇代谢重编程致染色质组蛋白乙酰化水平降低介导老年小鼠术后认知功能障碍
- 批准号:82371192
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
HK2乳酰化修饰介导巨噬细胞功能障碍在脓毒症中的作用及机制
- 批准号:82372160
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
组蛋白乙酰化修饰ATG13激活自噬在牵张应力介导骨缝Gli1+干细胞成骨中的机制研究
- 批准号:82370988
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
相似海外基金
Cytoskeletal Control of Yap in Heart Regeneration
Yap 在心脏再生中的细胞骨架控制
- 批准号:
10718408 - 财政年份:2023
- 资助金额:
$ 34.03万 - 项目类别:
Investigating essential chromatin regulators in cancers with SWI/SNF mutations
研究具有 SWI/SNF 突变的癌症中的必需染色质调节因子
- 批准号:
10607451 - 财政年份:2023
- 资助金额:
$ 34.03万 - 项目类别:
Role of SETD5 in Moyamoya Disease Pathogenesis
SETD5 在烟雾病发病机制中的作用
- 批准号:
10724796 - 财政年份:2023
- 资助金额:
$ 34.03万 - 项目类别:
Non-canonical mechanisms of gene regulation by the histone demethylase KDM5
组蛋白去甲基化酶 KDM5 基因调控的非典型机制
- 批准号:
10746913 - 财政年份:2023
- 资助金额:
$ 34.03万 - 项目类别:
Elucidating prostate cancer risk mechanisms through large-scale cistrome wide association studies
通过大规模顺反组广泛关联研究阐明前列腺癌风险机制
- 批准号:
10686418 - 财政年份:2022
- 资助金额:
$ 34.03万 - 项目类别:
Project 2: To determine the consequences of activating Rb function in cancer cells
项目 2:确定激活癌细胞中 Rb 功能的后果
- 批准号:
10597166 - 财政年份:2022
- 资助金额:
$ 34.03万 - 项目类别:
Project 2: To determine the consequences of activating Rb function in cancer cells
项目 2:确定激活癌细胞中 Rb 功能的后果
- 批准号:
10332381 - 财政年份:2022
- 资助金额:
$ 34.03万 - 项目类别:
Regulatory mechanisms governing imprinted domains during early development
早期发育过程中管理印记域的调控机制
- 批准号:
10697375 - 财政年份:2022
- 资助金额:
$ 34.03万 - 项目类别:
Identifying novel osteoarthritis risk genes using GWAS, chondrocyte genomics, and genome editing
使用 GWAS、软骨细胞基因组学和基因组编辑识别新的骨关节炎风险基因
- 批准号:
10706477 - 财政年份:2022
- 资助金额:
$ 34.03万 - 项目类别:
Regulatory mechanisms governing imprinted domains during early development
早期发育过程中管理印记域的调控机制
- 批准号:
10502723 - 财政年份:2022
- 资助金额:
$ 34.03万 - 项目类别: